Sort
48,018 grants matching “immunotherapy”
HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS
$635,173Tufts University Boston · R33 · FY2002 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
$635,077Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Molecular Diagnostics Core Laboratory
$635,058Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Transformative personalized vascular disrupting cancer immunotherapy
$635,042George Coukos · University Of Pennsylvania · R01 · FY2010 · CA
IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors
$635,004Andras A. Heczey · Baylor College Of Medicine · R01 · FY2022 · CA
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD
$634,976Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2020 · AG
Stomal Senescence Regulator of Tumor Immunity and Progression
$634,970David G Denardo · Washington University · R01 · FY2025 · CA
Specific Adoptive Immunotherapy of Leukemia
$634,912Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD
$634,903Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2021 · AG
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer
$634,894Stephanie Subasic Markovina · Washington University · R37 · FY2024 · CA
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease
$634,859Xiaobo Mao · Johns Hopkins University · R01 · FY2021 · AG
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$634,819Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level
$634,763Warren Phipps · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Three-dimensional conformation changes associated with T cell memory and autoimmunity
$634,757Raymond David Hawkins · University Of Washington · U01 · FY2021 · DK
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy
$634,736Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$634,715Elad Ziv · University Of California, San Francisco · R01 · FY2019 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells
$634,631Robbie B Mailliard · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
$634,556William E. Van Nostrand · University Of Rhode Island · R01 · FY2021 · NS
GPC2 CARs in neuroblastoma: Mechanisms of resistance and efficacy of next-generation constructs
$634,484Kristopher R Bosse · Children'S Hosp Of Philadelphia · R37 · FY2024 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$634,454Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2021 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$634,446Owen N Witte · University Of California Los Angeles · R01 · FY2022 · CA
Regulatory T cells in cancer therapy
$634,434Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$634,364Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA